Multiple myeloma and Metastatic renal cell carcinoma

Summary:

Metastatic renal cell carcinoma is found among people with Multiple myeloma, especially for people who are male, 60+ old.

The study analyzes which people have Metastatic renal cell carcinoma with Multiple myeloma. It is created by eHealthMe based on reports of 12 people who have Multiple myeloma from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Multiple myeloma?

Multiple myeloma (cancer of the plasma cells) is found to be associated with 1,109 drugs and 1,404 conditions by eHealthMe. Check the latest studies of Multiple myeloma.

What is Metastatic renal cell carcinoma?

Metastatic renal cell carcinoma (spreadable kidney cell tumour) is found to be associated with 260 drugs and 321 conditions by eHealthMe. Check the latest studies of Metastatic renal cell carcinoma.

On Jul, 16, 2026

12 people who have Multiple Myeloma and Metastatic Renal Cell Carcinoma are studied.

Would you have Metastatic renal cell carcinoma when you have Multiple myeloma?

Gender of people who have Multiple Myeloma and experienced Metastatic Renal Cell Carcinoma *:

female: 0.0 %
male: 100 %

Age of people who have Multiple Myeloma and experienced Metastatic Renal Cell Carcinoma *:

Common co-existing conditions for these people *:

Renal Cell Carcinoma (a kidney cancer): 2 people, 16.67%
Thrombosis (formation of a blood clot inside a blood vessel): 1 person, 8.33%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 8.33%
Constipation: 1 person, 8.33%
Diabetes: 1 person, 8.33%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 8.33%
Gastric Infection (infection of stomach): 1 person, 8.33%
Haemorrhoids (a swollen vein or group of veins in the region of the anus): 1 person, 8.33%
High Blood Pressure: 1 person, 8.33%
Hyperkalemia (damage to or disease of the kidney): 1 person, 8.33%

Common drugs taken by these people *:

Common symptoms for these people *:

Pneumonia: 3 people, 25.00%
Weakness: 2 people, 16.67%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 1 person, 8.33%
Hypoaesthesia (reduced sense of touch or sensation): 1 person, 8.33%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 8.33%
High Blood Pressure: 1 person, 8.33%
Haemoglobin Decreased: 1 person, 8.33%
Haematocrit Decreased: 1 person, 8.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 8.33%
Disease Progression: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Metastatic renal cell carcinoma?

- Check whether Metastatic renal cell carcinoma is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Metastatic renal cell carcinoma and Multiple myeloma, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.